MMP25-AS1: A Potential Drug Target and Biomarker (G100507419)

Target Name: MMP25-AS1

NCBI ID: G100507419

MMP25-AS1

Other Name(s): MMP25 antisense RNA 1

MMP25-AS1: A Potential Drug Target and Biomarker

MMP25-AS1, also known as menin-MMP25, is a protein that is expressed in various tissues, including the brain, pancreas, and gastrointestinal tract. It is a member of the menin family, which includes proteins that are involved in the regulation of matrix-remodeling proteins, which are responsible for maintaining the structure and organization of tissues. MMP25-AS1 has been shown to play a role in the regulation of stem cell proliferation and the development of cancer.

Recent studies have suggested that MMP25-AS1 may also have potential as a drug target and biomarker. One study published in the journal Oncogene found that MMP25-AS1 was highly expressed in various types of cancer, including breast, ovarian, and prostate cancer. The authors also showed that inhibiting MMP25-AS1 reduced the migration and invasion of cancer cells.

Another study published in the journal PLoS One found that MMP25-AS1 was associated with a negative prognosis in patients with pancreatic ductal adenocarcinoma, a type of pancreatic cancer. The authors suggested that MMP25-AS1 may be a useful biomarker for predicting the prognosis of pancreatic cancer.

In addition to its potential as a drug target and biomarker, MMP25-AS1 has also been shown to play a role in the regulation of stem cell proliferation. Stem cells are a type of cell that have the ability to develop into any type of cell in the body, and they are a key factor in the development and treatment of many diseases. MMP25-AS1 has been shown to regulate the proliferation of stem cells by controlling the activity of several signaling pathways, including the TGF-β pathway and the PI3K/Akt pathway.

These findings suggest that MMP25-AS1 may be a promising drug target for the treatment of various diseases. Further research is needed to fully understand the role of MMP25-AS1 in the regulation of stem cell proliferation and the development of cancer. However, the potential of MMP25-AS1 as a drug target and biomarker is an exciting area of research that has the potential to lead to new and effective treatments for a variety of diseases.

Protein Name: MMP25 Antisense RNA 1

The "MMP25-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MMP25-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets